News

Acella Pharmaceuticals, a specialty pharmaceutical company, has received approval of an Abbreviated New Drug Application (ANDA) for Gabapentin Oral Solution, 250 mg/5ml. The US Food and Drug Administration

The company said it will invest millions over the next year in two capital projects at its Merck Road packaging facility. The two projects include renovating existing manufacturing

Patients in the phase 2 study, which saw the enrollment of 130 women with low bone mass in multiple centers across the US, received one of three treatments:

Ficlatuzumab is a humanized IgG1 antibody that binds to the hepatocyte growth factor (HGF) ligand with high affinity and specificity to inhibit the biological activities of the HGF/c-Met

Janssen said the drug is used to treat patients with deep vein thrombosis (DVT) or pulmonary embolism (PE) and prevention of recurrent symptomatic venous thromboembolism (VTE). The company

Financial details for the research partnership have not been disclosed. As part of the research partnership, both companies will focus on screening for biased ligands against an undisclosed

The mobile cloud-based solution will eliminate servers, forgo the need of internal staff constantly upgrading software and improving the customers’ experience. Using MaaS360’s secure document sharing feature, the

Lorus has discovered IL-17E (also known as IL-25) cytokine that plays a vital role in inflammation and has potent anticancer properties. Lorus president and CEO Aiping Young said

The Study 116, a randomized, double-blind study, will enroll 160 patients to evaluate the utility of GS-1101 in combination with various chemoimmunotherapies in previously treated CLL patients. The